Search Icon
HLVX Archived Articles

HilleVax (HLVX): Navigating the Evolving Norovirus Vaccine Landscape

Published on November 30, 2024

HilleVax (NASDAQ:HLVX) Faces Setback as Norovirus Vaccine Trial in Infants Fails, But Adult Opportunity Remains

Published on September 24, 2024